Trial · NCT03803007
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Symptomatic intracranial haemorrhages | 24 hours | Number of participants experiencing a symptomatic haemorrhage defined by a secondary increase in National Institute Health Stroke Scale score by 4 points or greater, or death |
| Primary | Incidence of non-symptomatic intracranial haemorrhages | 24 hours | Non-symptomatic haemorrhages are those detected by Computerized Tomography scan |
| Secondary | Change from baseline of National Institute Health Stroke Scale score (7 minimum, 42 maximum), brain lesions and vessel recanalization | 24 hours | Absolute change from baseline of National Institute Health Stroke Scale score, change from baseline on brain lesions as assessed by Computerized Tomography scan or Magnetic Resonance Imaging or Magnetic Resonance Angiography, change from baseline on Recanalization as measured by the modified Thrombolysis In Cerebral Infarction score (0 minimum, 3 maximum) on Magnetic Resonance Angiography |
| Secondary | Change from baseline of National Institute Health Stroke Scale score (7 minimum, 42 maximum), brain lesions and vessel recanalization | 24 hours | Relative (%) change from baseline of National Institute Health Stroke Scale score, change from baseline on brain lesions as assessed by Computerized Tomography scan or Magnetic Resonance Imaging or Magnetic Resonance Angiography, change from baseline on Recanalization as measured by the modified Thrombolysis In Cerebral Infarction score (0 minimum, 3 maximum) on Magnetic Resonance Angiography |
| Secondary | Change from baseline of modified Ranking Scale score assessment | Day 90 | modified Ranking Scale score (0 minimum and 6 maximum): number of patients with favorable outcome (score 0-2) |
| Secondary | Change from baseline of modified Ranking Scale score assessment | Day 90 | modified Ranking Scale score (0 minimum and 6 maximum): percentage of patients with favorable outcome (score 0-2) |
| Secondary | Change from baseline on size of infarct zone | Day 7 | Change from baseline on size of infarct zone assessed by a central Magnetic Resonance Imaging review |
| Secondary | Change from baseline on vital signs | 6 hours, 24 hours, Day 7, Day 30 and Day 90 | Change from baseline on systolic and diastolic blood pressure |
| Secondary | Change from baseline on vital signs | 6 hours, 24 hours, Day 7, Day 30 and Day 90 | Change from baseline on heart rate |
| Secondary | Change from baseline on clinical laboratory assessments | Day 90 | Change from baseline on plasma haemoglobin level |
| Secondary | Change from baseline on clinical laboratory assessments | Day 90 | Change from baseline on platelet count |
| Secondary | Change from baseline on clinical laboratory assessments | Day 90 | Change from baseline on serum glucose concentration |
| Secondary | Change from baseline on clinical laboratory assessments | Day 90 | Change from baseline on serum creatinine concentration |
| Secondary | Change from baseline on ElectroCardioGram (ECG) | 24 hours and Day 90 | Change from baseline on 12-lead ElectroCardioGram (ECG) |
| Secondary | Evidence of anti-ACT017 antibodies (ADA) | Day 30 and Day 90 | To assess evidence of anti-ACT017 antibodies (ADA) as a possible to ACT017 administration |
| Secondary | Pharmacokinetics on ACT017 plasma concentration | 30 minutes, 9 hours and 24 hours | Change from baseline on ACT017 plasma concentration |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03803007/registered